Association between harmful alcohol consumption behavior and dopamine transporter (DAT1) gene polymorphisms in a male Finnish population

Psychiatric Genetics

Volumn 19, Issue 3, 2009, Pages 117-125

  Lind, Penelope A ^a   Eriksson, C J Peter ^b   Wilhelmsen, Kirk C ^c  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol abuse; Alcohol dependence; Alcohol use disorder identification test; Association study; Dopamine transporter; SLC6A3

Indexed keywords

DOPAMINE TRANSPORTER; PRIMER DNA; SLC6A3 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL REHABILITATION PROGRAM; ALCOHOL USE DISORDER IDENTIFICATION TEST; ALCOHOLISM; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRINKING BEHAVIOR; EXON; FINLAND; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT; GENETICS; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; TANDEM REPEAT;

3' UNTRANSLATED REGIONS; ALCOHOL DRINKING; ALLELES; BASE SEQUENCE; DNA PRIMERS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FINLAND; GENETICS, POPULATION; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TANDEM REPEAT SEQUENCES;

EID: 67649198995     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e32832a4f7b     Document Type: Article

References (44)

1. Babor TF, De La Fuente JR, Saunders JB, Grant M (1989). AUDIT: the Alcohol Use Disorders Identification Test: guidelines for use in primary health care. Geneva, Switzerland: World Health Organization.
2. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG (2002). AUDIT: the Alcohol Use Disorders Identification Test: guidelines for use in primary care. 2nd ed. Geneva, Switzerland: World Health Organization.
3. Baiter M (1996). New clues to brain dopamine control, cocaine addiction. Science 271:909.
4. Barrett JC, Fry B, Mailer J, Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
5. Boja JW, McNeill RM, Lewin AH, Abraham P, Carroll Fl, Kuhar MJ (1992). Selective dopamine transporter inhibition by cocaine analogs. Neumreport 3:984-986.
6. Dudbridge F (2003). Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115-121.
7. Foley PF, Loh EW, Innes DJ, Williams SM, Tannenberg AE, Harper CG, et al. (2004). Association studies of neurotransmitter gene polymorphisms in alcoholic Caucasians. Ann N Y Acad Sci 1025:39-46.
8. Franke P, Schwab SG, Knapp M, Gansicke M, Delmo C, Zill P, et al. (1999). DAT1 gene polymorphism in alcoholism: a family-based association study. Biol Psychiatry 45:652-654.
9. Gelernter J, Kranzler HR, Satel SL, Rao PA (1994). Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 11:195-200.
10. Gorwood P, Limosin F, Batel P, Hamon M, Ades J, Boni C (2003). The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biol Psychiatry 53:85-92.
11. Greenwood TA, Kelsoe JR (2003). Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics 82:511-520.
12. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, et al. (2001). Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet 105:145-151.
13. Grünhage F, Schulze TG, Muller DJ, Lanczik M, Franzek E, Albus M, et al. (2000). Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1). Mol Psychiatry 5:275-282.
14. Hahn MK, Blakely RD (2002). Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Pharmacogenomics J 2:217-235.
15. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, et al. (2000). Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22:133-139.
16. Heinz A, Goldman D, Gallinat J, Schumann G, Puis I (2004). Pharmacogenetic
17. insights to monoaminergic dysfunction in alcohol dependence. Psycho- pharmacology (Berl) 174:561-570.
18. Hodgson R, Alwyn T, John B, Thorn B, Smith A (2002). The FAST Alcohol Screening Test. Alcohol Alcohol 37:61-66.
19. Holmila M (1995). Intoxication and hazardous use of alcohol: results from the 1992 Finnish Drinking Habits Study. Addiction 90:785-792.
20. Kang AM, Palmatier MA, Kidd KK (1999). Global variation of a 40-bp VNTR in the 3'-untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry 46:151 -160.
21. Laine TP, Ahonen A, Torniainen P, Heikkila J, Pyhtinen J, Rasanen P, et al. (1999). Dopamine transporters increase in human brain after alcohol withdrawal. Mol Psychiatry 4:189-191:104-185.
22. Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, et al. (1999). Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 18:14-20.
23. Lin Z, Uhl GR (2003). Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities. Pharmacogenomics J 3:159-168.
24. Miller GM, Madras BK (2002). Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 7:44-55.
25. Muramatsu T, Higuchi S (1995). Dopamine transporter gene polymorphism and alcoholism. Biochem Biophys Res Commun 211:28-32.
26. Nyholt DR (2006). ssSNPer: identifying statistically similar SNPs to aid interpretation of genetic association studies. Bioinformatics 22:2960-2961.
27. Parsian A, Zhang ZH (1997). Human dopamine transporter gene polymorphism (VNTR) and alcoholism. Am J Med Genet 74:480-482.
28. Pirkola SP, Isometsa E, Suvisaari J, Aro H, Joukamaa M, Poikolainen K, et al. (2005). DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population - results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol 40:1-10.
29. Reid MC, Fiellin DA, O'Connor PG (1999). Hazardous and harmful alcohol consumption in primary care. Arch Intern Med 159:1681-1689.
30. Reinert DF, Allen JP (2002). The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research. Alcohol Clin Exp Res 26:272-279.
31. Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A, et al. (1997). Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry 41: 299-304.
32. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-ll. Addiction 88:791-804.
33. Schmidt LG, Harms H, Kuhn S, Rommelspacher H, Sander T (1998). Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am J Psychiatry 155:474-478.
34. Tühonen J, Kuikka J, Bergstrom K, Hakola P, Karhu J, Ryynanen OP, et al. (1995). Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nat Med 1:654-657.
35. Tupala E, Hall H, Sarkioja T, Rasanen P, Tühonen J (2000). Dopamine-transporter density in nucleus accumbens of type-1 alcoholics. Lancet 355:380.
36. Tupala E, Kuikka JT, Hall H, Bergstrom K, Sarkioja T, Rasanen P, et al. (2001). Measurement of the striatal dopamine transporter density and heterogeneity in type 1 alcoholics using human whole hemisphere autoradiography. Neuroimage 14:87-94.
37. Ueno S, Nakamura M, Mikami M, Kondoh K, Ishiguro H, Arinami T, et al. (1999). Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism. Mol Psychiatry 4:552-557.
38. Ujike H, Harano M, Inada T, Yamada M, Komiyama T, Sekine Y, et al. (2003). Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. Pharmacogenomics J 3:242-247.
39. Vandenbergh DJ, Thompson MD, Cook EH, Bendahhou E, Nguyen T, Krasowski MD, et al. (2000). Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations. Mol Psychiatry 5:283-292.
40. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, eral. (1996). Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 20:1594-1598.
41. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004). Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434-442.
42. Weiss F, Porrino U (2002). Behavioral neurobiology of alcohol addiction: recent advances and challenges. J Neurosci 22:3332-3337.
43. Wernicke C, Smolka M, Gallinat J, Winterer G, Schmidt LG, Rommelspacher H (2002). Evidence for the importance of the human dopamine transporter gene for withdrawal symptomatology of alcoholics in a German population. Neurosci Lett 333:45-48.
44. White FJ, Kalivas PW (1998). Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 51:141 -153.